163 related articles for article (PubMed ID: 26600901)
1. Treating childhood cancer in Rwanda: the nephroblastoma example.
Kanyamuhunga A; Tuyisenge L; Stefan DC
Pan Afr Med J; 2015; 21():326. PubMed ID: 26600901
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
3. Management of children with Wilms tumor in Africa and Europe; thoughts about costs, priorities and collaboration.
Israels T; Bailey S; Verschoor R; Kaspers GJ; Kennedy N; Molyneux EM
Pediatr Hematol Oncol; 2014 Aug; 31(5):395-9. PubMed ID: 25006872
[No Abstract] [Full Text] [Related]
4. Cost of Treating Pediatric Cancer at the Butaro Cancer Center of Excellence in Rwanda.
Neal C; Rusangwa C; Borg R; Mugunga JC; Kennell-Heiling S; Shyirambere C; Pritchett N; Muhayimana C; Ntakirutimana E; Tapela N; Park PH; Shulman LN; Mpunga T
J Glob Oncol; 2018 Nov; 4():1-7. PubMed ID: 30433841
[TBL] [Abstract][Full Text] [Related]
5. MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Tenge CN; Were PA; Aluoch LH; Wekesa JW; Patel K; Kuremu RT
East Afr Med J; 2012 Apr; 89(4):121-7. PubMed ID: 26856036
[TBL] [Abstract][Full Text] [Related]
6. Treatment of nephroblastoma in Africa: results of the first French African pediatric oncology group (GFAOP) study.
Moreira C; Nachef MN; Ziamati S; Ladjaj Y; Barsaoui S; Mallon B; Tournade MF
Pediatr Blood Cancer; 2012 Jan; 58(1):37-42. PubMed ID: 21850676
[TBL] [Abstract][Full Text] [Related]
7. Wilms tumor: five-year tumor-free survival on a modified SIOP protocol from an Indian university hospital.
Trehan A; Chowdhary SK; Marwaha RK
J Pediatr Hematol Oncol; 2012 Jan; 34(1):57-62. PubMed ID: 21423048
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials.
Rabeh W; Akel S; Eid T; Muwakkit S; Abboud M; El Solh H; Saab R
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):20-5. PubMed ID: 26802622
[TBL] [Abstract][Full Text] [Related]
9. The challenge of nephroblastoma in a developing country.
Ekenze SO; Agugua-Obianyo NE; Odetunde OA
Ann Oncol; 2006 Oct; 17(10):1598-600. PubMed ID: 16873431
[TBL] [Abstract][Full Text] [Related]
10. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
[TBL] [Abstract][Full Text] [Related]
11. [Nephroblastoma in children. Results of treatment (1989-1994)].
Sachivko NV; Drekov AG; Kochubinskiĭ VD; Sharak EV
Vopr Onkol; 1997; 43(4):422-5. PubMed ID: 9381695
[TBL] [Abstract][Full Text] [Related]
12. Challenge of pediatric oncology in Africa.
Hadley LG; Rouma BS; Saad-Eldin Y
Semin Pediatr Surg; 2012 May; 21(2):136-41. PubMed ID: 22475119
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Wilms' tumor: long-term survival and some epidemiological features.
Coppes MJ; de Kraker J; van Dijken PJ; Perry HJ; Delemarre JF; Tournade MF; Lemerle J; Voûte PA
J Clin Oncol; 1989 Mar; 7(3):310-5. PubMed ID: 2537383
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Different Protocols in Treatment of Nephroblastoma: A revisit.
Zakaria OM; Daoud MY; Farrag SH; Mulhim AS
Gulf J Oncolog; 2016 May; 1(21):55-60. PubMed ID: 27250889
[TBL] [Abstract][Full Text] [Related]
15. Continuing barriers to care of Wilms tumor in a low-income country.
Ekenze SO; Nwangwu EI; Ezomike UO; Orji EI; Okafor OO
Pediatr Blood Cancer; 2019 Jan; 66(1):e27416. PubMed ID: 30152039
[TBL] [Abstract][Full Text] [Related]
16. Experience and outcomes of nephroblastoma in Johannesburg, 1998 - 2003.
Rogers T; Bowley DM; Poole J; Swanepoel P; Wainwright J; Beale P; Pitcher G
Eur J Pediatr Surg; 2007 Feb; 17(1):41-4. PubMed ID: 17407020
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and treatment outcome in children with nephroblastoma in Kenya.
Abdallah FK; Macharia WM
East Afr Med J; 2001 Jul; 78(7 Suppl):S43-7. PubMed ID: 11957249
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumor: a 10 year retrospective study.
Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
